Referenze

 

1. Cotter P, Hill C, Ross RP. Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 2005;3:777-788.

2. De Jong A, van Heel AJ, Kok J, Kuipers OP. Bagels: mining for bacteriocins in genomic data. Nucleic Acids Res 2010;38:647-651.

3. Dobson A, Cotter PD, Ross RP, Hill C. Bacteriocin production as a probiotic trait. Appl Environ Microbiol 2012;78:1-6.

4. Casey PG, Gardiner GE, Casey G, et al. A five strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with Salmonella typhimurium. Appl Environ Microbiol 2007;73:1858-1863.

5. Milette M, Cornut G, Dupont C, et al. Capacity of human nisin- and pediocin- producing lactic acid bacteria to reduce intestinal colononazion by vancomycin-resistant enterococci. Appl Environ Microbiol 2008;74:1997-2003.

6. Hillman J. Genetically modified Streptococcus mutans for the prevention of dental caries. Antonie Van Leeuwenhoek 2002;82:361-366.

7. Balakrishnan M, Simmond RS, Carne A, Tagg JR. Streptococcus mutans strain N produces a novel low molecular mass non-lantibiotic bacteriocin. FEMS Microbiol Lett 2000;183:165-169.

8. Burton JP, Chilcott CN, Moore CJ, Spacer G, Tagg JR. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol 2006;100:754-764.

9. Tagg JR. Prevention of streptococcal pharyngitis by anti-pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. Indian J Med Res 2004;119(suppl):13-16.

10. Dover SE, Aroutcheva AA, Faro S, Chikindas ML. Natural antimicrobials and their role in vaginal health: a short review. Int J Probiotics Prebiotics 2008;3:219-230.

11. Corr SC, Li Y, Riedel CU, O’Toole PW, Hill C, Gahan CG. Bacteriocin production as a mechanism for the anti-infective activity of Lactobacillus salivarius UCC118.Proc Natl Acad Sci USA 2007;104:7617- 7621.

12. Alemayehu D, Casey P, McAuliffe O, et al. Bacteriophages MR299-2 and NH-4 can eliminate Pseudomonas aeruginosa in the nurine lung and on cystic fibrosis lung airway cells. Mbio 2012;3:e00029- 12.

13. Kankainen M, Paulin L, Tynkkynen S, et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili encoding a human-mucus binding protein. Proc Natl Acad Sci USA 2009;106:17193- 17198.

14. Mankley KJ, Fraenkel MB, Mayall BC, Power DA. Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Med J Aust 2007;186:454-457.

15. Motherway MO, Zomer A, Leahy SC, et al. Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor. Proc Natl Acad Sci USA 2011;108:11217-11222.

16. Schilling J, Wagner K, Seekiecher S, et al. Transcriptional activation of the tad type IVb pilus operon by PypB in Yersinia enterocolitica. J Bacteriol 2010;192:3809-3821.

17. Kamada N, Kim Y-G, Sham HP, et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 2012;336:1325-1329.

18. Crispie F, Alonso-Gomez M, O’Loughlin C, et al. Intramammary infusion of a live culture for treatment of bovine mastitis: effect of live lactococci on the mammary immune response. J Dairy Res 2008;75:374-384.

 

 

 

 

<< Torna alla Home